My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Target Posts Q3 Earnings Miss: Analysts Slash...
Natural Gas Prices Spike To Over 1-Year Highs...
Nvidia Delivered 'Jaw Dropping' Q3 Earnings,...
International Criminal Court Issues Arrest Wa...
Reddit Recovers from Major Service Outage On...
Uber Could Pick Up $10M Stake In Chinese Auto...
Tesla Registrations Drop By Over 20% In Octob...
Delta Chief Says Trump Could Be A 'Breath Of...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    REGENERON PHARMACEUTICALS INC (NASDAQ: REGN)

    Overview
    current price
    $753.05
    $753.05
    change
    9.70 | 1.30%
    9.70 | 1.30%
    Yesterday's Close
    743.35
    open
    744.87
    volume
    0.32 M
    30d. avg volume.
    0.81 M
    1 day
    735.95 - 757.56
    52 weeks
    736.01 - 1,211.20
    p/e
    18.39
    beta
    0.1459
    market cap
    80.34 B
    dividend yield
    0.00%
    Industry
    -
    REGN by TradingView
    News and Commentary
    Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst Wednesday, Johnson & Johnson (...
    After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stol... U.S. drug wholesaler Cencora Inc (
    AI Integration In Biotech & Pharma: Companies Positioned To Benefit The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug dis...
    $1 Billion Deal For Moderna To Expand Product Pipeline In China The defensive stocks sector has been underperforming most - if not all - of the remaining cyclical sectors in the U.S. economy. These preferences come from underlying dynamics in...
    FDA Pulls Authorization for GSK Antibody Drug Ineffective Against New Omicron Strain The U.S. Food and Drug Administration (FDA) has withdrawn its authorization for GlaxoSmithKline plc's
    FDA Withdraws Authorization for Regeneron and Eli Lilly Antibody Treatments For Use The U.S. Food and Drug Administration (FDA) has withdrawn its authorization for monoclonal antibody treatments manufactured by Regeneron
    Regeneron is Working on New Antibody Therapy for Omicron, Rival Therapies Show Mixed Results Against... Following lackluster data on the effectiveness of its COVID antibody therapy against the high mutated Omicron variant, Regeneron
    October 26 Market Update Global investors on Tuesday digested new data, policy statements, and earnings reports. In Europe, the British FTSE rose 0.76%, the German DAX climbed 1.01%, the French CAC rose...
    AstraZeneca's Antibody Therapy is 77% Effective at Preventing COVID Symptoms in Late-Stage Trial AstraZeneca's (AZN&nbsp...
    Regeneron Says Antibody Cocktail Can Prevent COVID Infection Regeneron Pharmaceuticals (RE...
    StockTwits
    StockTwits
    Most Shared
    SolarEdge Q3 Results Miss Expectations; Analysts Warn Of Cash Flow Challenges And Need For Cost Cuts
    US Economy Grows Less Than Expected In Q3, Yet Private Employment Soars By 233,000 In October
    Netflix Crash Hits Jake Paul-Mike Tyson Fight: Can Streaming Platform Handle Christmas Day NFL Action?
    Most Popular
    Meta, Amazon, Microsoft Partner On Defense AI Initiative
    Ford CEO Jim Farley Says He Tries To Drive All Vehicles From Competition After Expressing Adoration For Xiaomi SU7: 'Try Me,' Says Tesla Cybertruck
    Palantir Overtakes Lockheed Martin In Market Cap, How Does The 'Messi Of AI' Stack Up Against The Traditional Defense Player
    popular tags
    Earnings
    Coronavirus
    Apple
    Amazon
    Coronavirus Impact
    Covid-19
    Covid19
    Google
    Tesla
    mobile iOS Android
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2024 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?